Ebers GC - Search Results

1

Longitudinal analyses of the effects of neutralizing antibodies on interferon beta-1b in relapsing-remitting multiple sclerosis.

Petkau AJ, White RA, Ebers GC, Reder AT, Sibley WA, Lublin FD, Paty DW; IFNB Multiple Sclerosis Study Group. Petkau AJ, et al. Among authors: ebers gc. Mult Scler. 2004 Apr;10(2):126-38. doi: 10.1191/1352458504ms1004oa. Mult Scler. 2004. PMID: 15124756

2

Relationship between early clinical characteristics and long term disability outcomes: 16 year cohort study (follow-up) of the pivotal interferon β-1b trial in multiple sclerosis.

Goodin DS, Traboulsee A, Knappertz V, Reder AT, Li D, Langdon D, Wolf C, Beckmann K, Konieczny A, Ebers GC; 16-Year Long Term Follow-up Study Investigators. Goodin DS, et al. Among authors: ebers gc. J Neurol Neurosurg Psychiatry. 2012 Mar;83(3):282-7. doi: 10.1136/jnnp-2011-301178. Epub 2011 Dec 21. J Neurol Neurosurg Psychiatry. 2012. PMID: 22193561 Clinical Trial.

3

The evolution of neutralizing antibodies in multiple sclerosis patients treated with interferon beta-1b.

Rice GP, Paszner B, Oger J, Lesaux J, Paty D, Ebers G. Rice GP, et al. Neurology. 1999 Apr 12;52(6):1277-9. doi: 10.1212/wnl.52.6.1277. Neurology. 1999. PMID: 10214759 Clinical Trial.

4

Life expectancy in patients attending multiple sclerosis clinics.

Sadovnick AD, Ebers GC, Wilson RW, Paty DW. Sadovnick AD, et al. Among authors: ebers gc. Neurology. 1992 May;42(5):991-4. doi: 10.1212/wnl.42.5.991. Neurology. 1992. PMID: 1579256

5

Ibuprofen treatment versus gradual introduction of interferon beta-1b in patients with MS.

Rice GP, Ebers GC, Lublin FD, Knobler RL. Rice GP, et al. Among authors: ebers gc. Neurology. 1999 Jun 10;52(9):1893-5. doi: 10.1212/wnl.52.9.1893. Neurology. 1999. PMID: 10371541 Clinical Trial.

6

Cross-sectional study assessing long-term safety of interferon-beta-1b for relapsing-remitting MS.

Reder AT, Ebers GC, Traboulsee A, Li D, Langdon D, Goodin DS, Bogumil T, Beckmann K, Konieczny A; Investigators of the 16-Year Long-Term Follow-Up Study. Reder AT, et al. Among authors: ebers gc. Neurology. 2010 Jun 8;74(23):1877-85. doi: 10.1212/WNL.0b013e3181e240d0. Neurology. 2010. PMID: 20530324 Clinical Trial.

7

Cause of death in patients attending multiple sclerosis clinics.

Sadovnick AD, Eisen K, Ebers GC, Paty DW. Sadovnick AD, et al. Among authors: ebers gc. Neurology. 1991 Aug;41(8):1193-6. doi: 10.1212/wnl.41.8.1193. Neurology. 1991. PMID: 1866003

8

Immunotherapy for MS: clinical aspects and trials.

Ebers GC, Sibley WA, Paty DW. Ebers GC, et al. Acta Neurol Scand Suppl. 1995;161:54. doi: 10.1111/j.1600-0404.1995.tb05857.x. Acta Neurol Scand Suppl. 1995. PMID: 7653246 Clinical Trial. No abstract available.

9

Long-term follow-up of the original interferon-beta1b trial in multiple sclerosis: design and lessons from a 16-year observational study.

Ebers GC, Reder AT, Traboulsee A, Li D, Langdon D, Goodin DS, Wolf C, Beckmann K, Konieczny A; Investigators of the 16-Year Long-Term Follow-Up Study. Ebers GC, et al. Clin Ther. 2009 Aug;31(8):1724-36. doi: 10.1016/j.clinthera.2009.08.003. Clin Ther. 2009. PMID: 19808131

10

Studies in familial multiple sclerosis.

Ebers GC, Paty DW. Ebers GC, et al. Trans Am Neurol Assoc. 1980;105:344-7. Trans Am Neurol Assoc. 1980. PMID: 6960592 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

368 results

Search Page

Filters